期刊文献+

α亚族趋化因子受体3在人舌鳞癌细胞株的表达及其配体干扰素诱导蛋白-10对CAL-27细胞增殖和凋亡的影响 被引量:3

Chemokine receptor CXCR3 expression in different human tongue squamous cell carcinoma cell lines and the effect of IP-10/CXCL-10 on the proliferation and apoptosis of CAL-27 tongue cancer cells
下载PDF
导出
摘要 目的探讨α亚族趋化因子受体3(CXC-chemokine receptor 3,CXCR3)在不同人舌鳞癌细胞株的表达以及其配体干扰素诱导蛋白-10(interferon induced protein 10,IP-10)对人舌鳞癌细胞株CAL-27增殖和凋亡的影响。方法采用蛋白印迹法和免疫荧光染色对3种人舌鳞癌细胞株(CAL-27、UM-1、Tca-8113)IP-10的相应受体CXCR3的表达进行检测。CAL-27细胞被分为3个实验组和1个对照组,3个实验组根据IP-10的刺激浓度,分为10 ng/mL组、20 ng/mL组、40 ng/mL组,对照组不予刺激。12 h、24 h、48 h时检测4组细胞的增殖;24 h时用流式细胞仪检测细胞的凋亡。结果 CXCR3在3种人舌鳞癌细胞株均有表达,并且CXCR3在3株细胞的胞膜及胞质内均有染色。和对照组相比,12 h、24 h时,3种浓度的IP-10均能够促进CAL-27细胞增殖(P<0.05);在48 h时,只有40 ng/mL的IP-10能够促进CAL-27细胞增殖(P<0.05),10 ng/mL、20 ng/mL的IP-10对CAL-27细胞的增殖无促进作用(P>0.05)。在24 h时,对照组、10 ng/mL组、20 ng/mL组和40 ng/mL组的细胞凋亡率分别为(0.053 3±0.472 6)%、(3.236 7±0.940 0)%、(4.516 7±1.115 4)%和(3.363 3±0.571 2)%,3种浓度IP-10均能够促进CAL-27细胞的凋亡(P<0.05),但3个实验组之间差异无统计学意义(P>0.05)。结论CXCR3在3种人舌鳞癌细胞株的胞膜及胞质内均有表达;IP-10既能促进CAL-27细胞的增殖,又能促进其凋亡。随着时间的延长,IP-10的促增殖作用减弱,而这种减弱可能是由IP-10的促凋亡作用的逐步发挥所引起的。 To investigate the CXCR3 expression in different human tongue squamous cell carcinoma cell ]lines, and the effect of interferon-inducible protein-10 ([P-I0) on the proliferation and apoptosis of CAL-27 cell. Meth- ods Respectively, Western blot and immunofluorescence staining were used to examin the expression of CXCR3 on 3 different human tongue squamous cell carcinoma cell lines (CAL-27, UM-1, Tca-8113). Depending on the concentration of IP-10 stimulating, cells were divided into four groups: 0 ng/mL group (control group), 10 ng/mL group, 20 ng/mL group, 40 ng/mL groups. Culturing CAL-27ceIIs in vitro with IP-10 (0 ng/'mL, 10 ng/mL, 20 ng/mL, 40 ng/mL) , the proliferation with CCK-8 assay 'after 12 h, 24 h, 48 h were observed. Annexin V/PI double staining flow cytometry detec- ted the apoptosis of CAL-27, 'after 24 h treated with the same concentration gradient of IP-10. Results CXCR3 ex- pressed in three different human tongue squamous cell carcinoma ceils, stained in cell membrane and cytoplasm. Com- pared to the control group, 12 h and 24 h, different concentrations of IP-10 could promote the proliferation of CAL-27 (P〈0.05); 48 h, only 40 ng/mL IP-10 could promote the proliferation of CAL-27 cell (P 〈0.05), 10 ng/mL, 20 ng/mL IP-10 have no effect on the proliferation. After 24 h, apoptosis rate of control group, 10 ng/mL group, 20 ng/mL group and 40 ng/mL group were (0.053 3 ± 0.472 6) %, ( 3. 236 7± 0.940 0) %, (4.516 7 ± 1.115 4) % and ( 3. 363 3± 0.571 2 ) % respectively. IP-I 0 had a pm-apoptotic role on CAL-27 cells ( P 〈 0.05 ), but there was no significant difference between the different concentration groups (P 〉 0.05). Cortelusion IP-10 not only could promote CAL-27 cell proliferation, but also could promote apoptosis. With the extension of the duration of action, CAL-27 cell proliferation rate declines. The decline may be caused by gradually assuming IP-10 pro-apoptotic role.
出处 《广东牙病防治》 2013年第4期183-188,共6页 Journal of Dental Prevention and Treatment
基金 广东省科技计划项目(2010B031500032)
关键词 舌鳞状细胞癌 舌鳞癌细胞株 趋化因子受体3 干扰素诱导蛋白-10 Tongue squamous cell carcinoma Human tongue squamous cell carcinoma cell lines CXC-chemo-kine receptor 3 Interferon-inducible protein-10
  • 相关文献

参考文献17

  • 1Garin A, Proudfoot AE. Chemokines as targets for therapy. Exp Cell Res, 2011,317(5) :602-612.
  • 2Hoist PJ, Rosenkilde MM, Manfra D, et al. Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutiveactivity. J Clin Invest, 2001,108 ( 12 ) : 1789- 1796.
  • 3Burns JM, Summers BC, Wang Y, et al. A novel chemokine recep- tor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med, 2006,203 (9) :2201-2213.
  • 4Miao Z, Luker KE, Summers BC, et al. CXCR7 (RDC1) promotesbreast and lung tumor growth in vivo and is expressed on tumor-asso- ciated vasculature. Proc Natl Acad Sci U S A, 2007,104 (40): 15735-15740.
  • 5Mashino K, Sadanaga N, Yamaguchi H, et al. Expression of chemo- kine receptor CCR7 is associated with lymph node metastasis of gas- tric carcinoma. Cancer Res, 2002,62(10) :2937-2941.
  • 6冷红,张大志(审校).趋化因子IP-10的研究进展[J].国际免疫学杂志,2006,29(4):241-244. 被引量:16
  • 7Vandercappellen J, Van Damme J, Struyf S. The role of CXC che- mokines and their receptors in cancer. Cancer Lett, 2008,267 (2) : 226-244.
  • 8Strieter RM, Burdick MD, Gomperts BN, et al. CXC chemokines in angiogenesis. Cytokine Growth Factor Rev, 2005,16 (6) :593-609.
  • 9Kawada K, Sonoshita M, Sakashita H, et al. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Cancer Res, 2004,64 ( 11 ) :4010-4017.
  • 10Kawada K, Hosogi H, Sonoshita M, et al. Chemokine receptor CXCR.3 promotes colancancer metastasis to lymph nodes. Onco- gene, 2007,26(32) :4679-4688.

二级参考文献18

  • 1周钢,谭锦泉,章晓联.趋化因子与移植免疫[J].国外医学(免疫学分册),2004,27(4):185-189. 被引量:3
  • 2陈瑜,张德新,郭长存,乔泰东,樊代明,吴开春.趋化因子受体CXCR3在胃癌中的表达[J].胃肠病学,2004,9(5):266-269. 被引量:10
  • 3杨秀利,储以微,邓富刚,熊思东.IP10对机体抗肿瘤免疫应答的增强作用及其机制[J].中国免疫学杂志,2006,22(2):99-103. 被引量:8
  • 4Suzuki K,Kanabayashi T,Nakayama H,et al.Kinetics of chemokines and their receptors imercuric chloride induced tubulointerstitial lesions in brown norway rats.Exp Mol Pathol,2003,75(1):58-67.
  • 5Kouroumalis A,Nibbs RJ,Aptel H,et al.The chemokines CXCL9,CXCL10,and CXCL11 differentially stimulate G alpha i-independent signaling and actin responsee in human intestinal myofibroblasts.J lmmunol,2005,175(8):5403-5411.
  • 6Valbuena G,Bradford W,Walker DH.Expression analysis of the T-cell-targeting chemokines CXCL9 and CXCL10 in mice and humans with endothelial infections caused by rickettsiae of the spotted fever group.Am J Pathol,2003,163(4):1357-69.
  • 7Kimura K,Kakimi K,Wieland S,et al.Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice.J lmmunol,2002,169(9):5188-5195.
  • 8Park JW,Gruys ME,McCormick K,et al.Primary hepatocytes from mice treated with IL-2/IL-12 produce T cell chemoattractant activity that is dependent on monokine induced by IFN-gamma (Mig) and chemokine responsive to gamma-2 (Crg-2).J Immunol,2001,166(6):3763-3770.
  • 9Hensbergen PJ,van der Raaij-Helmer EM,Dijkman R,et al.Pro-cessing of natural and recombinant CXCR3-targeting chemokines and implications for biological activity.Eur J Biochem,2001,268(18):4992-4999.
  • 10Clark-Lewis I,Mattioli I,Gong JH,et al.Structure-function relationship between the human chemokine receptor CXCR3 and its ligands.J Biol Chem,2003,278(1):289-295.

共引文献15

同被引文献29

  • 1Scully C,Bagan J.Oral squamous cell carcinoma overview[J].Oral Oncol,2009,45(4/5):301-308.
  • 2Haddad RI,Shin DM.Recent advances in head and neck cancer[J].N Engl J Med,2008,359(11):1143-1154.
  • 3Dalgliesh GL,Furge K,Greenman C,et al.Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes [J].Nature,2010,463(7279):360-363.
  • 4Varela I,Tarpey P,Raine K,et al.Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma[ J ].Nature,2011,469(7392):539-542.
  • 5Van RE,Voest EE,Logister I,et al.Von hippel-lindau tumor suppressor mutants faithfully model pathological hypoxia-driven angiogenesis and vascular retinopathies in zebrafish[J].Dis Model Mech,2010,3(5/6):343-353.
  • 6Ponting CP,Belgard TG.Transcribed dark matter:meaning or myth? [J].Hum Mol Genet,2010,19(2):162-168.
  • 7Yang L,Duff MO,Graveley BR,et al.Genomewide characterization of non-polyadenylated RNA [J].Genome Biol,2011,12(2):R16.
  • 8Fossati A,Dolfini D,Donati G,et al.NF-Y recruits Ash2L to impart H3K4 trimethylation on CCAAT promoters[J].Plos One,2011,6(3):e17220.
  • 9Nagano T,Fraser P.No-nonsense functions for long non-coding RNA[J].Cell,2011,145(2):178-181.
  • 10Behran M,Puig I,Pefia C,et al.A natural antisense transcript regulates Zeb2/Sipl gene expression during Snaill-induced epithelial-mesenchymal transition [J].Gen Dev,2008,22(6):756-769.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部